137 related articles for article (PubMed ID: 29667823)
1. Luciferase Advisor: High-Accuracy Model To Flag False Positive Hits in Luciferase HTS Assays.
Ghosh D; Koch U; Hadian K; Sattler M; Tetko IV
J Chem Inf Model; 2018 May; 58(5):933-942. PubMed ID: 29667823
[TBL] [Abstract][Full Text] [Related]
2. Prediction of luciferase inhibitors by the high-performance MIEC-GBDT approach based on interaction energetic patterns.
Chen F; Sun H; Liu H; Li D; Li Y; Hou T
Phys Chem Chem Phys; 2017 Apr; 19(15):10163-10176. PubMed ID: 28374029
[TBL] [Abstract][Full Text] [Related]
3. Structural Analysis and Identification of False Positive Hits in Luciferase-Based Assays.
Yang ZY; Dong J; Yang ZJ; Lu AP; Hou TJ; Cao DS
J Chem Inf Model; 2020 Apr; 60(4):2031-2043. PubMed ID: 32202787
[TBL] [Abstract][Full Text] [Related]
4. Characterization of chemical libraries for luciferase inhibitory activity.
Auld DS; Southall NT; Jadhav A; Johnson RL; Diller DJ; Simeonov A; Austin CP; Inglese J
J Med Chem; 2008 Apr; 51(8):2372-86. PubMed ID: 18363348
[TBL] [Abstract][Full Text] [Related]
5. Discovery of 5-benzyl-3-phenyl-4,5-dihydroisoxazoles and 5-benzyl-3-phenyl-1,4,2-dioxazoles as potent firefly luciferase inhibitors.
Poutiainen PK; Palvimo JJ; Hinkkanen AE; Valkonen A; Väisänen TK; Laatikainen R; Pulkkinen JT
J Med Chem; 2013 Feb; 56(3):1064-73. PubMed ID: 23286196
[TBL] [Abstract][Full Text] [Related]
6. Reporter enzyme inhibitor study to aid assembly of orthogonal reporter gene assays.
Ho PI; Yue K; Pandey P; Breault L; Harbinski F; McBride AJ; Webb B; Narahari J; Karassina N; Wood KV; Hill A; Auld DS
ACS Chem Biol; 2013 May; 8(5):1009-17. PubMed ID: 23485150
[TBL] [Abstract][Full Text] [Related]
7. High throughput virtual screening and E-pharmacophore filtering in the discovery of new BACE-1 inhibitors.
Muthusamy K; Singh KhD; Chinnasamy S; Nagamani S; Krishnasamy G; Thiyagarajan C; Premkumar P; Anusuyadevi M
Interdiscip Sci; 2013 Jun; 5(2):119-26. PubMed ID: 23740393
[TBL] [Abstract][Full Text] [Related]
8. False positives in a reporter gene assay: identification and synthesis of substituted N-pyridin-2-ylbenzamides as competitive inhibitors of firefly luciferase.
Heitman LH; van Veldhoven JP; Zweemer AM; Ye K; Brussee J; IJzerman AP
J Med Chem; 2008 Aug; 51(15):4724-9. PubMed ID: 18646744
[TBL] [Abstract][Full Text] [Related]
9. Comparison of miniaturized time-resolved fluorescence resonance energy transfer and enzyme-coupled luciferase high-throughput screening assays to discover inhibitors of Rho-kinase II (ROCK-II).
Schröter T; Minond D; Weiser A; Dao C; Habel J; Spicer T; Chase P; Baillargeon P; Scampavia L; Schürer S; Chung C; Mader C; Southern M; Tsinoremas N; LoGrasso P; Hodder P
J Biomol Screen; 2008 Jan; 13(1):17-28. PubMed ID: 18227223
[TBL] [Abstract][Full Text] [Related]
10. Improving virtual screening predictive accuracy of Human kallikrein 5 inhibitors using machine learning models.
Fang X; Bagui S; Bagui S
Comput Biol Chem; 2017 Aug; 69():110-119. PubMed ID: 28601761
[TBL] [Abstract][Full Text] [Related]
11. A specific mechanism for nonspecific activation in reporter-gene assays.
Auld DS; Thorne N; Nguyen DT; Inglese J
ACS Chem Biol; 2008 Aug; 3(8):463-70. PubMed ID: 18590332
[TBL] [Abstract][Full Text] [Related]
12. A real-time bioluminescent HTS method for measuring protein kinase activity influenced neither by ATP concentration nor by luciferase inhibition.
Lundin A; Eriksson J
Assay Drug Dev Technol; 2008 Aug; 6(4):531-41. PubMed ID: 18532902
[TBL] [Abstract][Full Text] [Related]
13. [Development and Application of An Assay for High-throughput Antiviral Compounds Screening against Alphaviruses].
Wei Y; Li J; Wang H; Cen S; Liang G; Tan W; Zhu W
Bing Du Xue Bao; 2015 Nov; 31(6):641-6. PubMed ID: 26951009
[TBL] [Abstract][Full Text] [Related]
14. Titration-based screening for evaluation of natural product extracts: identification of an aspulvinone family of luciferase inhibitors.
Cruz PG; Auld DS; Schultz PJ; Lovell S; Battaile KP; MacArthur R; Shen M; Tamayo-Castillo G; Inglese J; Sherman DH
Chem Biol; 2011 Nov; 18(11):1442-52. PubMed ID: 22118678
[TBL] [Abstract][Full Text] [Related]
15. Case studies of minimizing nonspecific inhibitors in HTS campaigns that use assay-ready plates.
Liu Y; Beresini MH; Johnson A; Mintzer R; Shah K; Clark K; Schmidt S; Lewis C; Liimatta M; Elliott LO; Gustafson A; Heise CE
J Biomol Screen; 2012 Feb; 17(2):225-36. PubMed ID: 21940710
[TBL] [Abstract][Full Text] [Related]
16. Lies and Liabilities: Computational Assessment of High-Throughput Screening Hits to Identify Artifact Compounds.
Alves VM; Yasgar A; Wellnitz J; Rai G; Rath M; Braga RC; Capuzzi SJ; Simeonov A; Muratov EN; Zakharov AV; Tropsha A
J Med Chem; 2023 Sep; 66(18):12828-12839. PubMed ID: 37677128
[TBL] [Abstract][Full Text] [Related]
17. A printable hydrogel microarray for drug screening avoids false positives associated with promiscuous aggregating inhibitors.
Mateen R; Ali MM; Hoare T
Nat Commun; 2018 Feb; 9(1):602. PubMed ID: 29426913
[TBL] [Abstract][Full Text] [Related]
18. Experimental design and statistical methods for improved hit detection in high-throughput screening.
Malo N; Hanley JA; Carlile G; Liu J; Pelletier J; Thomas D; Nadon R
J Biomol Screen; 2010 Sep; 15(8):990-1000. PubMed ID: 20817887
[TBL] [Abstract][Full Text] [Related]
19. High-Throughput Cell Toxicity Assays.
Murray D; McWilliams L; Wigglesworth M
Methods Mol Biol; 2016; 1439():245-62. PubMed ID: 27317000
[TBL] [Abstract][Full Text] [Related]
20. Complementarity between a docking and a high-throughput screen in discovering new cruzain inhibitors.
Ferreira RS; Simeonov A; Jadhav A; Eidam O; Mott BT; Keiser MJ; McKerrow JH; Maloney DJ; Irwin JJ; Shoichet BK
J Med Chem; 2010 Jul; 53(13):4891-905. PubMed ID: 20540517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
